France restricts intravascular radiation therapy
This article was originally published in Clinica
Executive Summary
The French healthcare products safety agency, AFSSAPS, has published on its website a report on the risks and benefits of intravascular radiation therapy products used to prevent restenosis in coronary stents. This is the only FDA-approved treatment for in-stent restenosis and the report was considered a priority because the technique is new (some two years old) and potentially risky.